CN103977279A - 一种治疗母猪子宫炎的中药添加剂及其制备方法 - Google Patents
一种治疗母猪子宫炎的中药添加剂及其制备方法 Download PDFInfo
- Publication number
- CN103977279A CN103977279A CN201410194402.XA CN201410194402A CN103977279A CN 103977279 A CN103977279 A CN 103977279A CN 201410194402 A CN201410194402 A CN 201410194402A CN 103977279 A CN103977279 A CN 103977279A
- Authority
- CN
- China
- Prior art keywords
- weight portions
- weight
- weight portion
- herba
- portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 104
- 239000000654 additive Substances 0.000 title claims abstract description 70
- 230000000996 additive effect Effects 0.000 title claims abstract description 70
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 241000746375 Andrographis Species 0.000 claims abstract description 27
- 241000222640 Polyporus Species 0.000 claims abstract description 27
- 241001481710 Cerambycidae Species 0.000 claims abstract description 26
- 241000757701 Cyananthus Species 0.000 claims abstract description 26
- 235000015489 Emblica officinalis Nutrition 0.000 claims abstract description 26
- 244000119298 Emblica officinalis Species 0.000 claims abstract description 26
- 241001362856 Lepisorus miyoshianus Species 0.000 claims abstract description 26
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 26
- 241001453798 Nephrolepis Species 0.000 claims description 50
- 239000000463 material Substances 0.000 claims description 33
- 238000011282 treatment Methods 0.000 claims description 29
- 241000894006 Bacteria Species 0.000 claims description 28
- 241000628997 Flos Species 0.000 claims description 27
- 239000009636 Huang Qi Substances 0.000 claims description 27
- 210000000582 semen Anatomy 0.000 claims description 27
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 27
- 210000004291 uterus Anatomy 0.000 claims description 27
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 25
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 25
- 241001330002 Bambuseae Species 0.000 claims description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 25
- 239000011425 bamboo Substances 0.000 claims description 25
- 239000000706 filtrate Substances 0.000 claims description 24
- 206010061218 Inflammation Diseases 0.000 claims description 23
- 230000004054 inflammatory process Effects 0.000 claims description 22
- 235000014676 Phragmites communis Nutrition 0.000 claims description 21
- 238000010438 heat treatment Methods 0.000 claims description 15
- 238000000605 extraction Methods 0.000 claims description 13
- 238000010992 reflux Methods 0.000 claims description 13
- 230000001476 alcoholic effect Effects 0.000 claims description 12
- 239000013521 mastic Substances 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 11
- 239000003610 charcoal Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 238000000227 grinding Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 239000002245 particle Substances 0.000 claims description 6
- 230000002829 reductive effect Effects 0.000 claims description 6
- 241000411851 herbal medicine Species 0.000 abstract description 10
- 230000009286 beneficial effect Effects 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 4
- 239000003640 drug residue Substances 0.000 abstract description 3
- 241000748223 Alisma Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000049464 Artemisia apiacea Species 0.000 abstract 1
- 235000011570 Artemisia caruifolia var apiacea Nutrition 0.000 abstract 1
- 241000209128 Bambusa Species 0.000 abstract 1
- 241001646078 Bjerkandera fumosa Species 0.000 abstract 1
- 241001247438 Chonemorpha Species 0.000 abstract 1
- 244000192528 Chrysanthemum parthenium Species 0.000 abstract 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 1
- 240000004270 Colocasia esculenta var. antiquorum Species 0.000 abstract 1
- 235000002723 Dioscorea alata Nutrition 0.000 abstract 1
- 235000007056 Dioscorea composita Nutrition 0.000 abstract 1
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 abstract 1
- 235000005362 Dioscorea floribunda Nutrition 0.000 abstract 1
- 235000004868 Dioscorea macrostachya Nutrition 0.000 abstract 1
- 235000005361 Dioscorea nummularia Nutrition 0.000 abstract 1
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 235000013719 Houttuynia cordata Nutrition 0.000 abstract 1
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 abstract 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 240000000982 Malva neglecta Species 0.000 abstract 1
- 235000000060 Malva neglecta Nutrition 0.000 abstract 1
- 235000003805 Musa ABB Group Nutrition 0.000 abstract 1
- 240000008790 Musa x paradisiaca Species 0.000 abstract 1
- 241001453796 Nephrolepis cordifolia Species 0.000 abstract 1
- 235000004347 Perilla Nutrition 0.000 abstract 1
- 244000124853 Perilla frutescens Species 0.000 abstract 1
- 235000015266 Plantago major Nutrition 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract 1
- 240000009022 Smilax rotundifolia Species 0.000 abstract 1
- 235000003205 Smilax rotundifolia Nutrition 0.000 abstract 1
- 244000250129 Trigonella foenum graecum Species 0.000 abstract 1
- 240000000099 Zanthoxylum avicennae Species 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 235000004879 dioscorea Nutrition 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 231100000053 low toxicity Toxicity 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 239000001917 trigonella foenum graecum l. absolute Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 41
- 239000008280 blood Substances 0.000 description 41
- 230000000694 effects Effects 0.000 description 39
- 208000002193 Pain Diseases 0.000 description 30
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 29
- 210000003734 kidney Anatomy 0.000 description 25
- 201000010099 disease Diseases 0.000 description 24
- 239000000243 solution Substances 0.000 description 21
- 230000001737 promoting effect Effects 0.000 description 20
- 230000001717 pathogenic effect Effects 0.000 description 17
- 239000000796 flavoring agent Substances 0.000 description 16
- 235000019634 flavors Nutrition 0.000 description 16
- 210000004185 liver Anatomy 0.000 description 16
- 231100000614 poison Toxicity 0.000 description 16
- 210000000952 spleen Anatomy 0.000 description 16
- 208000004880 Polyuria Diseases 0.000 description 15
- 230000035619 diuresis Effects 0.000 description 15
- 210000001015 abdomen Anatomy 0.000 description 13
- 235000009508 confectionery Nutrition 0.000 description 13
- 208000001848 dysentery Diseases 0.000 description 13
- 210000004072 lung Anatomy 0.000 description 13
- 210000002784 stomach Anatomy 0.000 description 13
- 230000007812 deficiency Effects 0.000 description 12
- 206010030113 Oedema Diseases 0.000 description 11
- 229940079593 drug Drugs 0.000 description 11
- 239000002398 materia medica Substances 0.000 description 11
- 206010011224 Cough Diseases 0.000 description 10
- 206010037660 Pyrexia Diseases 0.000 description 10
- 239000007789 gas Substances 0.000 description 10
- 208000014674 injury Diseases 0.000 description 10
- 239000003440 toxic substance Substances 0.000 description 10
- 230000012173 estrus Effects 0.000 description 9
- 244000052769 pathogen Species 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 8
- 208000006820 Arthralgia Diseases 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 7
- 208000033809 Suppuration Diseases 0.000 description 7
- 210000000038 chest Anatomy 0.000 description 7
- 239000003172 expectorant agent Substances 0.000 description 7
- 230000003419 expectorant effect Effects 0.000 description 7
- 231100000252 nontoxic Toxicity 0.000 description 7
- 230000003000 nontoxic effect Effects 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 7
- 210000003932 urinary bladder Anatomy 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 206010047700 Vomiting Diseases 0.000 description 6
- 230000001154 acute effect Effects 0.000 description 6
- 230000036528 appetite Effects 0.000 description 6
- 235000019789 appetite Nutrition 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 231100000331 toxic Toxicity 0.000 description 6
- 230000002588 toxic effect Effects 0.000 description 6
- -1 4.24 milligrams Chemical compound 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 206010017553 Furuncle Diseases 0.000 description 5
- 208000003251 Pruritus Diseases 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 206010013990 dysuria Diseases 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 230000002147 killing effect Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 210000003097 mucus Anatomy 0.000 description 5
- 230000008736 traumatic injury Effects 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 208000008454 Hyperhidrosis Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 201000007100 Pharyngitis Diseases 0.000 description 4
- 206010040943 Skin Ulcer Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 4
- 231100000869 headache Toxicity 0.000 description 4
- 208000014617 hemorrhoid Diseases 0.000 description 4
- 210000002414 leg Anatomy 0.000 description 4
- 201000007227 lymph node tuberculosis Diseases 0.000 description 4
- 208000004396 mastitis Diseases 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 230000001047 pyretic effect Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 231100000019 skin ulcer Toxicity 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 231100000820 toxicity test Toxicity 0.000 description 4
- 210000001113 umbilicus Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 3
- 208000004429 Bacillary Dysentery Diseases 0.000 description 3
- 208000002881 Colic Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 3
- 206010060891 General symptom Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010019909 Hernia Diseases 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 206010035664 Pneumonia Diseases 0.000 description 3
- 206010067171 Regurgitation Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 241000130764 Tinea Species 0.000 description 3
- 208000002474 Tinea Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 206010046793 Uterine inflammation Diseases 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 201000004171 acute endometritis Diseases 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 230000003628 erosive effect Effects 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 201000003453 lung abscess Diseases 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 201000005113 shigellosis Diseases 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 208000019206 urinary tract infection Diseases 0.000 description 3
- 210000003905 vulva Anatomy 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 208000004145 Endometritis Diseases 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 208000000260 Warts Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 206010001093 acute tonsillitis Diseases 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 229940069428 antacid Drugs 0.000 description 2
- 239000003159 antacid agent Substances 0.000 description 2
- 230000001458 anti-acid effect Effects 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 210000003756 cervix mucus Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000030373 chronic endometritis Diseases 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 231100000895 deafness Toxicity 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000035558 fertility Effects 0.000 description 2
- 229940124600 folk medicine Drugs 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000003779 hair growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000016354 hearing loss disease Diseases 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000001473 noxious effect Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- NDTYTMIUWGWIMO-UHFFFAOYSA-N perillyl alcohol Chemical compound CC(=C)C1CCC(CO)=CC1 NDTYTMIUWGWIMO-UHFFFAOYSA-N 0.000 description 2
- RUMOYJJNUMEFDD-UHFFFAOYSA-N perillyl aldehyde Chemical compound CC(=C)C1CCC(C=O)=CC1 RUMOYJJNUMEFDD-UHFFFAOYSA-N 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 201000010153 skin papilloma Diseases 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 208000006379 syphilis Diseases 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 241000027431 Anoplophora Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- UYIFTLBWAOGQBI-BZDYCCQFSA-N Benzhormovarine Chemical compound C([C@@H]1[C@@H](C2=CC=3)CC[C@]4([C@H]1CC[C@@H]4O)C)CC2=CC=3OC(=O)C1=CC=CC=C1 UYIFTLBWAOGQBI-BZDYCCQFSA-N 0.000 description 1
- 208000031636 Body Temperature Changes Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010009152 Chronic tonsillitis Diseases 0.000 description 1
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- VJGGHXVGBSZVMZ-QIZQQNKQSA-N Cloprostenol Chemical compound C([C@H](O)\C=C\[C@@H]1[C@H]([C@@H](O)C[C@H]1O)C\C=C/CCCC(O)=O)OC1=CC=CC(Cl)=C1 VJGGHXVGBSZVMZ-QIZQQNKQSA-N 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000371997 Eriocheir sinensis Species 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 208000019637 Infantile Diarrhea Diseases 0.000 description 1
- 208000029836 Inguinal Hernia Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000027530 Meniere disease Diseases 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 241000117280 Naematelia aurantialba Species 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- MAYJEFRPIKEYBL-OASIGRBWSA-N Obacunone Chemical compound C=1([C@@H]2OC(=O)[C@H]3O[C@@]43[C@]3(C)C(=O)C[C@H]5C(C)(C)OC(=O)C=C[C@]5(C)[C@H]3CC[C@]42C)C=COC=1 MAYJEFRPIKEYBL-OASIGRBWSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000543821 Oestrus Species 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 240000004760 Pimpinella anisum Species 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000020264 Puerperal Infection Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000607760 Shigella sonnei Species 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000001203 Smallpox Diseases 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 208000033041 Somatoform disorder gastrointestinal Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 241000244155 Taenia Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 241000287411 Turdidae Species 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 241000870995 Variola Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 208000016150 acute pharyngitis Diseases 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000036523 atherogenesis Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 208000003796 chancre Diseases 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 229960004409 cloprostenol Drugs 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229950002007 estradiol benzoate Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000009027 insemination Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 230000001983 lactogenic effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 150000002814 niacins Chemical class 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- VSLDMVSILHVDSR-UHFFFAOYSA-N obacunone Natural products CC1(C)OC(=O)C=CC2(C)C1CC(=O)C3(C)C2CCC4(C)C(OC(=O)C5OC345)c6occc6 VSLDMVSILHVDSR-UHFFFAOYSA-N 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 210000005000 reproductive tract Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 208000012991 uterine carcinoma Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗母猪子宫炎的中药添加剂及其制备方法,其中,中药添加剂包括以下原料药材:金银花、马鬃参、黄柏、车前子、猪苓、蝤蛴、泽泻、甘草、簕竹、当归、川芎、益母草、黄芪、花萆薢、穿心莲、苦参、鱼腥草、肾蕨、青蒿、紫苏、丝带蕨、山药、淫羊藿、五味子、庵摩勒、芦巴子、枳壳、亚黑管菌、乌药、锦葵、簕欓、海螵蛸和大萼鹿角藤。本发明的有益效果是:采用这种中药添加剂对患有母猪子宫炎的治疗,具有毒副作用低、成本低廉、无药物残留量、降低死亡率和治愈率高等优点。
Description
技术领域
本发明涉及动物饲料技术领域,尤其涉及一种治疗母猪子宫炎的中药添加剂及其制备方法。
背景技术
母猪子宫炎是母猪分娩及产后,子宫有时受到感染而发生炎症。病因有:难产,胎衣不下,子宫脱出,助产时手术不洁,操作粗野,造成子宫损伤,产后感染,以及人工授精时消毒不彻底,自然交配时公猪生殖器官或精液内有致病菌,炎性分泌物等可引起子宫内膜炎。母猪营养不良。瘦弱,抵抗力下降时,其生殖道内非致病菌也能引起发病。
母猪子宫炎可分为急性与慢性子宫内膜炎。①急性子宫内膜炎:全身症状明显,母猪体温升高,精神不振,食欲减退或废绝,时常努责,特别在母猪刚卧下时,阴道内流出白色粘液或带臭味污秽不洁红褐色粘液或脓性分泌物,分泌物粘于尾根部,腥臭难闻。有时母猪出现腹痛症状。急性子宫炎多发生于产后及流产后。②慢性子宫内膜炎:多由急性子宫内膜炎治疗不及时转化而来。病猪全身症状不明显。病猪可能周期性的从阴道内排出少量混浊的粘液。母猪往往推迟发情,或发情不正常,即使能定期发情,也屡配不孕。
母猪子宫内膜炎是困扰规模化猪场养猪的一个重要问题,近几年来,有逐步蔓延的趋势,发病率20%左右,有的猪场发病率可高达40%以上。母猪子宫内膜炎是猪繁殖障碍病中的主要疾病之一,病因极为复杂,国内外研究表明本病的病原涉及多种病原微生物。此病多发于产后,部分未配种的后备母猪也可能发生,患猪若得不到及时有效地治疗,往往会转为隐性或慢性感染,泌乳量减少、无乳或乳汁质量差,不愿给仔猪哺乳,致使哺乳仔猪拉稀,发育不良;发情周期紊乱,屡配不孕,产仔少,产死胎等疾病,如果发展成顽固性子宫炎后,则会增加生产母猪淘汰率,并容易继发感染其他疾病,而加大猪场的损失。
中兽医学认为本病是由于行经、产后胞脉空虚,邪毒乘虚内侵,热毒缠积下焦,气滞血瘀,肝经积郁,大伤正气,虚寒夹杂之症。属带下病范畴。发生子宫炎的母猪一般全身症状不明显,只是表现为食欲下降或不食,从阴道内流出白色或淡黄色粘液(脾肾虚弱型),或从阴道流出黄色粘稠物,附着在尾根、阴户的周围,腥臭难闻(湿热下注型),或从阴道流出如米泔样粘液,夹带血块或脓,带恶臭,影响泌乳(热毒壅盛型),多数猪不出现体温变化,亦有猪体温轻度升高,断乳后母猪仍未愈者发情推迟或不发情,影响受胎。
但是,目前在规模化猪场生产中,母猪发生子宫炎较为常见,由于该病的病因较复杂,不易对症治疗,因而,西药治疗往往疗效不显,影响哺乳仔猪生长,母猪发情推迟,给生产带来较大损失。
发明内容
本发明所要解决的技术问题是在于提供一种治疗母猪子宫炎的中药添加剂及其制备方法,采用这种中药添加剂对患有母猪子宫炎的治疗,具有毒副作用低,成本低廉,无药物残留量、降低死亡率,治愈率高等优点。
为了实现上述发明目的,本发明提供了促进仔猪生长的中药添加剂,所述中药添加剂包括以下原料药材:金银花、马鬃参、黄柏、车前子、猪苓、蝤蛴、泽泻、甘草、簕竹、当归、川芎、益母草、黄芪、花萆薢、穿心莲、苦参、鱼腥草、肾蕨、青蒿、紫苏、丝带蕨、山药、淫羊藿、五味子、庵摩勒、芦巴子、枳壳、亚黑管菌和乌药。
其中,中药添加剂中各原料药材的重量份数优选为:金银花15-30重量份、马鬃参10-30重量份、黄柏20-30重量份、车前子20-35重量份、猪苓15-30重量份、蝤蛴10-30重量份、泽泻10-30重量份、甘草20-35重量份、簕竹10-30重量份、当归15-30重量份、川芎10-30重量份、益母草10-30重量份、黄芪15-35重量份、花萆薢10-30重量份、穿心莲20-35重量份、苦参10-30重量份、鱼腥草15-30重量份、肾蕨20-35重量份、青蒿20-35重量份、紫苏15-30重量份、丝带蕨10-30重量份、山药25-35重量份、淫羊藿10-30重量份、五味子15-30重量份、庵摩勒10-30重量份、芦巴子20-35重量份、枳壳10-30重量份、亚黑管菌20-35重量份和乌药15-30重量份。
其中,中药添加剂中各原料药材的重量份数还可以优选为:金银花17-30重量份、马鬃参15-30重量份、黄柏25-30重量份、车前子20-30重量份、猪苓15-25重量份、蝤蛴15-30重量份、泽泻15-30重量份、甘草20-30重量份、簕竹15-30重量份、当归20-30重量份、川芎15-30重量份、益母草15-30重量份、黄芪15-30重量份、花萆薢15-30重量份、穿心莲20-30重量份、苦参15-30重量份、鱼腥草20-30重量份、肾蕨20-30重量份、青蒿25-35重量份、紫苏20-30重量份、丝带蕨15-30重量份、山药25-30重量份、淫羊藿15-30重量份、五味子15-20重量份、庵摩勒15-30重量份、芦巴子25-35重量份、枳壳15-30重量份、亚黑管菌20-30重量份和乌药15-25重量份。
其中,中药添加剂中各原料药材的重量份数又可以优选为:金银花25重量份、马鬃参22重量份、黄柏26重量份、车前子20重量份、猪苓18重量份、蝤蛴17重量份、泽泻18重量份、甘草22重量份、簕竹18重量份、当归22重量份、川芎18重量份、益母草16重量份、黄芪18重量份、花萆薢20重量份、穿心莲22重量份、苦参18重量份、鱼腥草22重量份、肾蕨20重量份、青蒿25重量份、紫苏22重量份、丝带蕨18重量份、山药28重量份、淫羊藿18重量份、五味子17重量份、庵摩勒16重量份、芦巴子28重量份、枳壳19重量份、亚黑管菌22重量份和乌药18重量份。
其中,所述中药添加剂还包括:锦葵、簕欓、海螵蛸和大萼鹿角藤。
其中,所述中药添加剂中各原料药材的重量份数优选为:金银花15-30重量份、马鬃参10-30重量份、黄柏20-30重量份、车前子20-35重量份、猪苓15-30重量份、蝤蛴10-30重量份、泽泻10-30重量份、甘草20-35重量份、簕竹10-30重量份、当归15-30重量份、川芎10-30重量份、益母草10-30重量份、黄芪15-35重量份、花萆薢10-30重量份、穿心莲20-35重量份、苦参10-30重量份、鱼腥草15-30重量份、肾蕨20-35重量份、青蒿20-35重量份、紫苏15-30重量份、丝带蕨10-30重量份、山药25-35重量份、淫羊藿10-30重量份、五味子15-30重量份、庵摩勒10-30重量份、芦巴子20-35重量份、枳壳10-30重量份、亚黑管菌20-35重量份、乌药15-30重量份、锦葵10-25重量份、簕欓15-30重量份、海螵蛸10-35重量份和大萼鹿角藤20-30重量份。
其中,中药添加剂中各原料药材的重量份数还可以优选为:金银花20重量份、马鬃参18重量份、黄柏22重量份、车前子22重量份、猪苓18重量份、蝤蛴15重量份、泽泻18重量份、甘草22重量份、簕竹18重量份、当归17重量份、川芎15重量份、益母草18重量份、黄芪19重量份、花萆薢20重量份、穿心莲22重量份、苦参19重量份、鱼腥草20重量份、肾蕨22重量份、青蒿25重量份、紫苏20重量份、丝带蕨18重量份、山药28重量份、淫羊藿18重量份、五味子17重量份、庵摩勒20重量份、芦巴子25重量份、枳壳18重量份、亚黑管菌25重量份、乌药19重量份、锦葵15重量份、簕欓25重量份、海螵蛸18重量份和大萼鹿角藤22重量份。
其中,中药添加剂中各原料药材的重量份数又可以优选为:金银花18重量份、马鬃参17重量份、黄柏22重量份、车前子25重量份、猪苓25重量份、蝤蛴20重量份、泽泻18重量份、甘草22重量份、簕竹19重量份、当归20重量份、川芎18重量份、益母草17重量份、黄芪18重量份、花萆薢19重量份、穿心莲22重量份、苦参17重量份、鱼腥草18重量份、肾蕨22重量份、青蒿25重量份、紫苏18重量份、丝带蕨19重量份、山药27重量份、淫羊藿19重量份、五味子18重量份、庵摩勒15重量份、芦巴子22重量份、枳壳18重量份、亚黑管菌22重量份、乌药18重量份、锦葵18重量份、簕欓18重量份、海螵蛸20重量份和大萼鹿角藤25重量份。
为了更好的实现上述发明目的,本发明还提供了治疗母猪子宫炎的中药添加剂的制备方法,所述制备方法包括以下步骤:
步骤一、按照重量份数称取所有原料药材,并粉碎成40目-60目的粉末状;
步骤二、将上述所得粉末进行炭炒1.0-2.5小时,随后加入相对于混合物质量2-4倍的醇浓度为75%-85%乙醇溶液,加热回流提取4.5-7小时,获得第一提取液,过滤,获得第一过滤液;滤渣再次加入相对于其质量2-5倍的醇浓度为65%-90%乙醇溶液,加热回流提取1.5-3小时,获得第二提取液,过滤,获得第二过滤液,将第一过滤液和第二过滤液合并,搅拌混合,减压浓缩、除去乙醇,获得干膏体,随后采用粉碎机将所得干膏体粉碎,粉碎粒度270目-400目,获得粉末状的所述中药添加剂。
本发明实施例提供的技术方案带来的有益效果是:采用这种中药添加剂对患有母猪子宫炎的治疗,具有毒副作用低,成本低廉,无药物残留量、降低死亡率,治愈率高等优点。
具体实施方式
本发明提供了一种治疗母猪子宫炎的中药添加剂,中药添加剂包括以下原料药材:金银花、马鬃参、黄柏、车前子、猪苓、蝤蛴、泽泻、甘草、簕竹、当归、川芎、益母草、黄芪、花萆薢、穿心莲、苦参、鱼腥草、肾蕨、青蒿、紫苏、丝带蕨、山药、淫羊藿、五味子、庵摩勒、芦巴子、枳壳、亚黑管菌、乌药、锦葵、簕欓、海螵蛸和大萼鹿角藤。
其中,各原料药材的药理特性为:
金银花:性寒,味甘,入肺、心、胃经,具有清热解毒、抗炎、补虚疗风的功效,主治胀满下疾、温病发热,热毒痈疡和肿瘤等症。其对于头昏头晕、口干作渴、多汗烦闷、肠炎、菌痢、麻疹、肺炎、乙脑、流脑、急性乳腺炎、败血症、阑尾炎、皮肤感染、痈疽疔疮、丹毒、腮腺炎、化脓性扁桃体炎等病症均有一定疗效。同时金银花茶有独特的减肥功能,还能抑制与杀灭咽喉部的病原菌,对老人和儿童有抗感染功效。所以,经常服用金银花浸泡或煎剂有利于风火目赤、咽喉肿痛、肥胖症、肝热症和肝热型高血压的治疗与康复。
黄柏:性味苦寒,有清热燥湿,泻火除蒸,解毒疗疮之功效,常用中药,其性寒、味苦,具清热燥湿、泻火解毒等功效,常用于湿热泻痢、黄疸、白带以及热痹、热淋等症。现代研究表明,黄柏含小蘖碱、黄柏酮等主要成分,有抗菌、收敛、消炎的作用,对各种皮肤湿毒、疮疡等症状,功效良好。《本经逢原》曰:“黄柏,生用降实火,酒制治阴火上炎,盐制治下焦之火,姜制治中焦痰火,姜汁炒黑治湿热,盐酒炒黑制虚火,阴虚火盛面赤戴阳,附子汁制”。
车前子:甘;淡;性微寒。归肺经;肝经;肾经;膀胱经。具有清热利尿;渗湿止泻;明目;祛痰的功能。主治:主小便不利;淋浊带下;水肿胀满;暑湿泻痢;目赤障翳;痰热咳喘。现代药理实验表明:在试管内,车前水浸剂对同心性毛癣菌、许兰黄癣菌、奥杜盎小芽胞癣菌、铁锈色小芽胞癣菌、羊毛状小芽胞癣菌、星形奴卡菌等皮肤真菌有不同程度的抑制作用。亦有报告指出,对多种致病菌,如金黄色葡萄球菌、宋内痢疾杆菌、大肠杆菌、绿脓杆菌及伤寒杆菌亦有不同程度的抑制作用。车前醇提取物(15mg/ml)对钩端螺旋体有杀灭作用。
猪苓:味甘、淡,平。入心,脾,胃,肺,肾、经。具有的功效:利水渗湿。治小便不利,水肿、泄泻,淋浊,带下。猪苓为我国常用的菌类药材,已有2000多年的药用历史,在国内外享有盛誉。它不仅具有利尿和抗菌作用,经研究发现有抗癌作用,需要量将会逐年增加。
泽泻:是传统的中药之一。中医理论认为其性寒,具有利水渗湿的功效。现代医学研究,泽泻可降低血清总胆固醇及三酰甘油含量,减缓动脉粥样硬化形成;泽泻及其制剂现代还用于治疗内耳眩晕症、血脂异常、遗精、脂肪肝及糖尿病等。
甘草:治五脏六腑寒热邪气,坚筋骨,长肌肉,倍气力,解毒,久服轻身延年。生用泻火热,熟用散表寒,去咽痛,除邪热,缓正气,养阴血,补脾胃,润肺,长于温中,以甘温益气,缓急止痛力强。用于脾虚胃弱,心悸脉结代等。粉甘草,善治尿道痛,尿路淋,生草节宜消肿毒、利关节;粉甘草,偏重清内热,泻心火。同是一物,其炮制所不同,则功效主治亦别。
当归:适用于血虚诸证;月经不调;经闭;痛经;症瘕结聚;崩漏;虚寒腹痛;痿痹;肌肤麻木;肠燥便难;赤痢后重;痈疽疮疡;跌扑损伤。1.功效:用治中风不省人事、口吐白沫、产后风瘫。① 抗缺氧作用;② 调节机体免疫功能、具有抗癌作用;③ 护肤美容作用;④ 补血活血作用;⑤ 抑菌、抗动脉硬化作用。
川芎:辛温香燥,走而不守,既能行散,上行可达巅顶;又入血分,下行可达血海。活血祛瘀作用广泛,适宜瘀血阻滞各种病症;祛风止痛,效用甚佳,可治头风头痛、风湿痹痛等症。 昔人谓川芎为血中之气药,殆言其寓辛散、解郁、通达、止痛等功能。《本经》:主中风入脑头痛,寒痹,筋挛缓急,金创,妇人血闭无子。《别录》:除脑中冷动,面上游风去来,目泪出,多涕唾,忽忽如醉,诸寒冷气,心腹坚痛,中恶,卒急肿痛,胁风痛,温中内寒。陶弘景:齿根出血者,含之多瘥。《药性论》:治腰脚软弱,半身不遂,主胞衣不出,治腹内冷痛。《日华子本草》:治一切风,一切气,一切劳损,一切血,补五劳,壮筋骨,调众脉,破症结宿血,养新血,长肉,鼻洪,吐血及溺血,痔瘘,脑痈发背,瘰疬瘿赘,疮疥,及排脓消瘀血。《医学启源》:补血,治血虚头痛。王好古:搜肝气,补肝血,润肝燥,补风虚。《纲目》:燥湿,止泻痢,行气开郁。
益母草:味苦、辛,性微寒,入肝、心包经,具有活血调经,利尿消肿,清热解毒的作用,用于血瘀所致的月经不调,痛经,经闭,产后腹痛或恶露不尽;水肿,小便不利;跌打损伤,疮痈肿毒等证。
黄芪:味甘,性微温,归肝、脾、肺、肾经。有益气固表、敛汗固脱、托疮生肌、利水消肿之功效。在中医五行理论中,春季对应的是肝脏,因此,调养肝气对于春季的养生至关重要。黄芪作为补气佳品,在春季生发的季节能够起到一定的补气作用。黄芪熬粥汤,具有益血补气之功效。
穿心莲:又名春莲秋柳,一见喜,榄核莲、苦胆草、金香草、金耳钩、印度草,苦草等。有清热解毒、消炎、消肿止痛作用。主治细菌性痢疾、尿路感染、急性扁桃体炎、肠炎、咽喉炎、肺炎和流行性感冒等,外用可治疗疮疖肿毒、外伤感染等。穿心莲具有消炎解毒作用,临床上曾应用于多种感染性疾病,包括外伤感染、疖、痈、丹毒、上呼吸道感染、急慢性扁桃体炎、急慢性咽喉炎、急慢性支气管炎、急性菌痢、急性胃肠炎、尿路感染、子宫内膜炎、盆腔炎、中耳炎、牙周炎等,均有不同程度的疗效。
苦参:有抗菌消炎的作用,对痤疮杆菌、金黄色葡萄球菌、大肠 杆菌均有抑制作用,能利尿、抗过敏、镇痛、平喘、祛痰。味苦;性寒。归肝;肾;大肠;小肠经;膀胱;心经;膀胱经。功效:清热燥湿:广泛应用与多重湿热病症,如湿热泻痢 外用可以煎汤外洗,用于痔疮,妇女妇科;杀虫(外用),利尿。可清热燥湿;祛风杀虫。主湿热泻痢;肠风便血;黄疸;小便不利;水肿;带下;阴痒;疥癣;麻风;皮肤瘙痒;湿毒疮疡。《本草纲目》曰:“苦参、黄柏之苦寒,皆能补肾,盖取其苦燥湿,寒除热也。热生风,湿生虫,故又能治风杀虫。惟肾水弱而相火胜者用之相宜,若火衰精冷,真元不足,及年高之人不可用也。张从正亦云,凡药皆毒也,虽甘草、苦参,不可不谓之毒,久服则五味各归其脏,必有偏胜气增之患,诸药皆然,学者当触类而长之可也,至于饮食亦然。又按《史记》云,太仓公淳于意医齐大夫病龋齿,灸左手阳明脉,以苦参汤日漱三升,出入慎风,五、六日愈,此亦取其去风气湿热杀虫之义”。
鱼腥草:性微寒,味苦,《纲目》记载其:“辛,微温,有小毒”.归肺经、膀胱、大肠经。具有清热解毒;排脓消痈;利尿通淋的功用,主治肺痈吐脓;痰热喘咳,可治疗治肺炎,肺脓疡。《滇南本草》记载其:“治肺痈咳嗽带脓血,痰有腥臭”.鱼腥草中提得的一种黄色油状物,对各种微生物(尤其是酵母菌和霉菌)均有抑制作用,对溶血性的链球菌、金黄色葡萄球菌、流感杆菌、卡他球菌、肺炎球菌有明显的抑制作用,且鱼腥草还具有抗病毒的作用。
青蒿:性味:苦,辛,寒。归肝、胆经、三焦、肾经。功用:清透虚热,凉血除蒸,除蒸,截疟。用于暑邪发热,阴虚发热,夜热早凉,骨蒸劳热,疟疾寒热,湿热黄疸。该品苦寒清热,辛香透散,善使阴分伏热透达外散,为阴虚发热要药,此外有解暑,截虐之功。
紫苏:辛,温。归肺、脾经。可发汗解表,理气宽中,解鱼蟹毒。用于风寒感冒,头痛,咳嗽,胸腹胀满,鱼蟹中毒。紫苏叶性温味辛,具有解表、散寒、理气、和营的功效。适用于感冒风寒、恶寒发热、咳嗽、气喘、胸腹胀满等病症。紫苏全株均有很高的营养价值,它具有低糖、高纤维、高胡萝卜素、高矿质元素等。在嫩叶中每100克含还原糖0.68~1.26克,蛋白质3.84克,纤维素3.49~6.96克,脂肪1.3克,胡萝卜素7.94~9.09毫克,维生素B1 0.02毫克,维生素B2 0.35毫克,尼克酸1.3毫克,维生素C55~68毫克,钾522毫克,钠4.24毫克,钙217毫克,镁70.4毫克,磷65.6毫克,铜0.34毫克,铁20.7毫克,锌1.21毫克,锰1.25毫克,锶1.50毫克,硒3.24~4.23微克,挥发油中含紫苏醛、紫苏醇、薄荷酮、薄荷醇、丁香油酚、白苏烯酮等。抗衰老素SOD在每毫克苏叶中含量高达106.2微克。经研究发现,紫苏各部位均匀具有很好的抗癌作用,尤以叶片中的作用更强,其中的齐墩果酸既是一种很强的天然抗癌剂,具有预防肿瘤的作用,又具有消炎、镇静、强心、利尿、增强免疫力、降血脂和抵制癌细胞生长的作用。紫苏既能发汗散寒以解表邪,又能行气宽中、解郁止呕,故对风寒表症而兼见胸闷呕吐症状的,使用本品,很是适宜;或无表症而有气滞不畅症状的,也可用于宣通。
山药:补脾养胃,生津益肺,补肾涩精。用于脾虚食少,久泻不止,肺虚喘咳,肾虚遗精,带下,尿频,虚热消渴。麸炒山药补脾健胃。用于脾虚食少,泄泻便溏,白带过多。该品养阴能助湿,所以湿盛中满、或有积滞、有实邪者不宜。
淫羊藿:全草供药用。主治阳萎早泄,腰酸腿痛,四肢麻木,半身不遂,神经衰弱,健忘,耳鸣,目眩等症。淫羊藿是中国常用中药。
五味子:别名:玄及,会及,五梅子,山花椒,壮味,五味等,唐等《新修本草》载“五味皮肉甘酸,核中辛苦,都有咸味”,故有五味子之名。古医书称它荎蕏、玄及、会及,最早列于神农本草经上品,中药功效在于滋补强壮之力,药用价值极高。
芦巴子:味苦,性温。入肾、肝经。主治寒疝,腹胁胀满,寒湿脚气,肾虚腰酸,阳痿。用于肾脏虚冷,小腹冷痛,小肠疝气,寒湿脚气。种子的油有催乳作用。《嘉祐本草》云:"主元脏虚冷气。得附子、硫黄,治肾虚冷,腹胁胀满,面色青黑;得茴香子、桃仁,治膀胱气甚效。"《本草纲目》云:"治冷气疝瘕,寒湿脚气,益右肾,暖丹田。"又"元阳不足,冷气潜伏,不能归元者宜之。"
枳壳:破气,行痰,消积。治胸膈痰滞,胸痞,胁胀,食积,噫气,呕逆,下痢后重,脱肛,子宫脱垂。①《药性论》:治遍身风疹,肌中如麻豆恶痒,主肠风痔疾,心腹结气,两胁胀虚,关膈拥塞。②《日华子本草》:健脾开胃,调五脏,下气,止呕逆,消痰。治反胃,霍乱泻痢,消食,破症结痃癖,五膈气,除风明目及肺气水肿,利大小肠,皮肤痒。痔肿可炙熨。③《开宝本草》:主风痒麻痹,通利关节,劳气咳嗽,背膊闷倦,散留结、胸膈痰滞,逐水,消胀满、大肠风,安胃,止风痛。④《珍珠囊》:破气,泄肺中不利之气。⑤《医学启源》:《主治秘诀》云,破心下坚痞,利胸中气,化痰,消食⑥《纲目》:治里急后重。
乌药:性味辛,温。入胃,肾经。功效:舒气,温中,散寒,止痛。乌药具有较为广泛的药理活性,主要如下:抗菌、抗病毒作用乌药对心肌有兴奋作用,其挥发油内服有兴奋心肌、加速回流循环、升压及发汗作用,亦有兴奋大脑皮质、促进呼吸作用,局部涂用可使血管扩张、加快血液循环、缓解复合肌肉痉挛性疼痛作用。乌药配伍当归乌药辛开温通,行气解郁、散寒止痛,偏走气分;当归辛散温运,养血活血、调经止痛,偏走血分。二者伍用,共奏行气活血、散寒温经止痛之功效,用于治疗寒凝气滞血淤之痛经、产后腹痛以及寒疝等症。乌药配伍木香乌药行气止痛散寒,长于温散下焦寒湿;木香行气止痛,功擅行脾胃气滞。两药相须为用,其散寒、行气、止痛之功效更著,用于治疗寒凝气滞所致之脘腹胀痛以及胃肠神经官能症属气滞不通者。
马鬃参:性味:甘;苦;性温;主治:健脾附温;舒筋活络。主脾虚乏力;小儿泄泻;风湿痹痛;跌打损伤。
蝤蛴:又称桔褐天牛,性味: 辛,平。主治:通经络,化瘀血。主治痨伤血瘀,闭经,腰脊疼痛,跌打瘀积,疼痛。
簕竹:性味:竹叶:甘,凉。主治:竹茹:清热利尿;凉血止痢,清热生津。小儿高热,感冒风热,尿路感染,鼻衄,消化不良,痢疾,为热呕吐,呃逆。
红萆薢:性味: ①《四川中药志》:"苦,平,无毒。"②《云南中草药选》:"甘淡,平。"归经: 《四川中药志》:"入肝、胃、肾三经。"主治: ①《四川中药志》:"祛风湿,分清浊,利关节,解疮毒。治风湿痛,腰膝痹痛。小便淋浊及梅毒恶疮。"②《云南中草药选》:"祛风除湿,通淋,利水,消炎,解毒。治风湿性关节炎,泌尿系感染,慢性胃炎,月经不调,疮疖。"
肾蕨:性味:苦辛,平。①《贵州民间药物》:"性平,味苦,无毒。"②《四川中药志》:"性温,味淡辛,无毒。"③《泉州本草》:"味甘辛,性平而涩,无毒。"归经:《泉州本草》:"入肝、肾、胃、小肠经。"主治:清热,利湿,消肿,解毒。治黄疸,淋浊,小便涩痛,痢疾,疝气,乳痈,瘰疬,烫伤,刀伤。①《贵州民间药物》:"清热。治刀伤,吐血,淋浊,不孕。"②《四川中药志》:"治乳痈及产后乳肿。"③《泉州本草》:"清热解毒,利小便。治湿热黄疸,小便不利,反胃噎膈,疝气。"④《广西实用中草药新选》:"治肺热咳嗽,蜈蚣咬伤,汤火伤,小儿疳积,淋巴腺结核。"
丝带蕨:性味:甘;凉。归经:肝;肾经。主治:清热熄风;活血。主小儿惊风;劳伤。
庵摩勒: 性味:苦甘,寒。①《唐本草》:"味苦甘,寒,无毒。"②《海药本草》:"味苦酸甘,微寒,无毒。"归经:《四川中药志》:"入脾,胃二经。"主治: 化痰,生津,止咳,解毒。治感冒发热,咳嗽咽痛,白喉,烦热口干。①《唐本草》:"主风虚热气。"②《本草拾遗》:"主补益,强气力。取子压取汁和油涂头生发,去风痒,初涂发脱,后生如漆。"③《海药本草》:"主上气咳嗽。"④《南宁市药物志》:"清凉解毒,治喉痹。"⑤广州部队《常用中草药手册》:"润肺化痰,生津止渴。"
亚黑管菌:性味:微涩;平。主治:抗癌,主子宫癌。
锦葵:性味:咸;寒。主治: 利尿通便;清热解毒。主大小便不畅;带下;淋巴结结核;咽喉肿痛。
簕欓:性味:苦、辛,微温。主治:祛风利湿,活血止痛。根:黄疸型肝炎,肾炎水肿,风湿性关节炎。果:胃痛,腹痛。叶:跌打损伤,腰肌劳损,乳腺炎,疖肿。
海螵蛸:性味:咸,微温。①《本经》:"味咸,微温。"②《吴普本草》:"冷。"③《别录》:"无毒。"④《药性论》:"有小毒。"归经: 入肝、肾经。①《纲目》:"厥阴血分。"②《雷公炮制药性解》:"入肾经。"③《本草再新》:"入肝、脾、肾三经。"主治: 除湿,制酸,止血,敛疮。治胃痛吞酸,吐、衄、呕血,便血,崩漏带下,血枯经闭,腹痛症瘕,虚疟泻痢,阴蚀烂疮。①《本经》:"主女子漏下赤白经汁,血闭,阴蚀肿痛,寒热症瘕,无子。"②《别录》:"惊气入腹,腹痛环脐,阴中寒肿(一作"丈夫阴中肿痛》),又止疮多脓汁不燥。"③《药性论》:"止妇人漏血,主耳聋。"④《唐本草》:"疗人目中翳。"⑤《食疗本草》:"主小儿大人下痢,炙今黄,去皮细研成粉,粥中调服之。"⑥《本草拾遗》:"主妇人血瘕,杀小虫。"⑦《日华子本草》:"疗血崩。"⑧《纲目》:"主女子血枯病,伤肝,唾血下血,治疟消瘿。研末敷小儿疳疮,痘疮臭烂,丈夫阴疮,汤火伤,跌伤出血。烧存性,同鸡子黄涂小儿重舌、鹅口,同蒲黄末敷舌肿血出如泉,同银朱吹鼻治喉痹,同麝香吹耳治聤耳有脓及耳聋。"⑨《要药分剂》:"通经络,去寒湿。"⑩《现代实用中药》:"为制酸药,对胃酸过多、胃溃疡有效。"
大萼鹿角藤:性味: 辛;性温。归经: 肺;肾经。主治:祛风通络;活血止痛。主风寒湿痹;腰膝冷痛;跌打损伤;外伤出血。
其中,中药添加剂中各原料药材的重量份数优选为:金银花15-30重量份、马鬃参10-30重量份、黄柏20-30重量份、车前子20-35重量份、猪苓15-30重量份、蝤蛴10-30重量份、泽泻10-30重量份、甘草20-35重量份、簕竹10-30重量份、当归15-30重量份、川芎10-30重量份、益母草10-30重量份、黄芪15-35重量份、花萆薢10-30重量份、穿心莲20-35重量份、苦参10-30重量份、鱼腥草15-30重量份、肾蕨20-35重量份、青蒿20-35重量份、紫苏15-30重量份、丝带蕨10-30重量份、山药25-35重量份、淫羊藿10-30重量份、五味子15-30重量份、庵摩勒10-30重量份、芦巴子20-35重量份、枳壳10-30重量份、亚黑管菌20-35重量份和乌药15-30重量份。
其中,中药添加剂中各原料药材的重量份数还可以优选为:金银花17-30重量份、马鬃参15-30重量份、黄柏25-30重量份、车前子20-30重量份、猪苓15-25重量份、蝤蛴15-30重量份、泽泻15-30重量份、甘草20-30重量份、簕竹15-30重量份、当归20-30重量份、川芎15-30重量份、益母草15-30重量份、黄芪15-30重量份、花萆薢15-30重量份、穿心莲20-30重量份、苦参15-30重量份、鱼腥草20-30重量份、肾蕨20-30重量份、青蒿25-35重量份、紫苏20-30重量份、丝带蕨15-30重量份、山药25-30重量份、淫羊藿15-30重量份、五味子15-20重量份、庵摩勒15-30重量份、芦巴子25-35重量份、枳壳15-30重量份、亚黑管菌20-30重量份和乌药15-25重量份。
其中,中药添加剂中各原料药材的重量份数又可以优选为:金银花25重量份、马鬃参22重量份、黄柏26重量份、车前子20重量份、猪苓18重量份、蝤蛴17重量份、泽泻18重量份、甘草22重量份、簕竹18重量份、当归22重量份、川芎18重量份、益母草16重量份、黄芪18重量份、花萆薢20重量份、穿心莲22重量份、苦参18重量份、鱼腥草22重量份、肾蕨20重量份、青蒿25重量份、紫苏22重量份、丝带蕨18重量份、山药28重量份、淫羊藿18重量份、五味子17重量份、庵摩勒16重量份、芦巴子28重量份、枳壳19重量份、亚黑管菌22重量份和乌药18重量份。
其中,所述中药添加剂还包括:锦葵、簕欓、海螵蛸和大萼鹿角藤。
其中,中药添加剂中各原料药材的重量份数优选为:金银花15-30重量份、马鬃参10-30重量份、黄柏20-30重量份、车前子20-35重量份、猪苓15-30重量份、蝤蛴10-30重量份、泽泻10-30重量份、甘草20-35重量份、簕竹10-30重量份、当归15-30重量份、川芎10-30重量份、益母草10-30重量份、黄芪15-35重量份、花萆薢10-30重量份、穿心莲20-35重量份、苦参10-30重量份、鱼腥草15-30重量份、肾蕨20-35重量份、青蒿20-35重量份、紫苏15-30重量份、丝带蕨10-30重量份、山药25-35重量份、淫羊藿10-30重量份、五味子15-30重量份、庵摩勒10-30重量份、芦巴子20-35重量份、枳壳10-30重量份、亚黑管菌20-35重量份、乌药15-30重量份、锦葵10-25重量份、簕欓15-30重量份、海螵蛸10-35重量份和大萼鹿角藤20-30重量份。
其中,中药添加剂中各原料药材的重量份数还可以优选为:金银花20重量份、马鬃参18重量份、黄柏22重量份、车前子22重量份、猪苓18重量份、蝤蛴15重量份、泽泻18重量份、甘草22重量份、簕竹18重量份、当归17重量份、川芎15重量份、益母草18重量份、黄芪19重量份、花萆薢20重量份、穿心莲22重量份、苦参19重量份、鱼腥草20重量份、肾蕨22重量份、青蒿25重量份、紫苏20重量份、丝带蕨18重量份、山药28重量份、淫羊藿18重量份、五味子17重量份、庵摩勒20重量份、芦巴子25重量份、枳壳18重量份、亚黑管菌25重量份、乌药19重量份、锦葵15重量份、簕欓25重量份、海螵蛸18重量份和大萼鹿角藤22重量份。
其中,中药添加剂中各原料药材的重量份数又可以优选为:金银花18重量份、马鬃参17重量份、黄柏22重量份、车前子25重量份、猪苓25重量份、蝤蛴20重量份、泽泻18重量份、甘草22重量份、簕竹19重量份、当归20重量份、川芎18重量份、益母草17重量份、黄芪18重量份、花萆薢19重量份、穿心莲22重量份、苦参17重量份、鱼腥草18重量份、肾蕨22重量份、青蒿25重量份、紫苏18重量份、丝带蕨19重量份、山药27重量份、淫羊藿19重量份、五味子18重量份、庵摩勒15重量份、芦巴子22重量份、枳壳18重量份、亚黑管菌22重量份、乌药18重量份、锦葵18重量份、簕欓18重量份、海螵蛸20重量份和大萼鹿角藤25重量份。
中药添加剂的制备方法包括以下步骤:
步骤一、按照重量份数称取所有原料药材,并粉碎成40目-60目的粉末状;
步骤二、将上述所得粉末进行炭炒1.0-2.5小时,随后加入相对于混合物质量2-4倍的醇浓度为75%-85%乙醇溶液,加热回流提取4.5-7小时,获得第一提取液,过滤,获得第一过滤液;滤渣再次加入相对于其质量2-5倍的醇浓度为65%-90%乙醇溶液,加热回流提取1.5-3小时,获得第二提取液,过滤,获得第二过滤液,将第一过滤液和第二过滤液合并,搅拌混合,减压浓缩、除去乙醇,获得干膏体,随后采用粉碎机将所得干膏体粉碎,粉碎粒度270目-400目,获得粉末状的所述中药添加剂。
实施例1中药添加剂1
本发明实施例提供了一种治疗母猪子宫炎的中药添加剂,由以下重量份数的原料药材制成:金银花25重量份、马鬃参22重量份、黄柏26重量份、车前子20重量份、猪苓18重量份、蝤蛴17重量份、泽泻18重量份、甘草22重量份、簕竹18重量份、当归22重量份、川芎18重量份、益母草16重量份、黄芪18重量份、花萆薢20重量份、穿心莲22重量份、苦参18重量份、鱼腥草22重量份、肾蕨20重量份、青蒿25重量份、紫苏22重量份、丝带蕨18重量份、山药28重量份、淫羊藿18重量份、五味子17重量份、庵摩勒16重量份、芦巴子28重量份、枳壳19重量份、亚黑管菌22重量份和乌药18重量份。
中药添加剂通过以下制备方法制得:
步骤一、按照上述重量份数称取所有原料药材,并粉碎成45目的粉末;
步骤二、将上述所得粉末进行炭炒2.5小时,随后加入相对于混合物质量2.5倍的醇浓度为75%乙醇溶液,加热回流提取4.5小时,获得第一提取液,过滤,获得第一过滤液;滤渣再次加入相对于其质量3倍的醇浓度为70%乙醇溶液,加热回流提取2小时,获得第二提取液,过滤,获得第二过滤液,将第一过滤液和第二过滤液合并,搅拌混合,减压浓缩、除去乙醇,获得干膏体,随后采用粉碎机将所得干膏体粉碎,粉碎粒度320目,获得粉末状的所述中药添加剂。
实施例2中药添加剂2
本发明实施例提供了一种治疗母猪子宫炎的中药添加剂,由以下重量份数的原料药材制成:金银花20重量份、马鬃参18重量份、黄柏22重量份、车前子22重量份、猪苓18重量份、蝤蛴15重量份、泽泻18重量份、甘草22重量份、簕竹18重量份、当归17重量份、川芎15重量份、益母草18重量份、黄芪19重量份、花萆薢20重量份、穿心莲22重量份、苦参19重量份、鱼腥草20重量份、肾蕨22重量份、青蒿25重量份、紫苏20重量份、丝带蕨18重量份、山药28重量份、淫羊藿18重量份、五味子17重量份、庵摩勒20重量份、芦巴子25重量份、枳壳18重量份、亚黑管菌25重量份、乌药19重量份、锦葵15重量份、簕欓25重量份、海螵蛸18重量份和大萼鹿角藤22重量份。
中药添加剂通过以下制备方法制得:
步骤一、按照重量份数称取所有原料药材,并粉碎成55目的粉末;
步骤二、将上述所得粉末进行炭炒3小时,随后加入相对于混合物质量3倍的醇浓度为80%乙醇溶液,加热回流提取5小时,获得第一提取液,过滤,获得第一过滤液;滤渣再次加入相对于其质量3倍的醇浓度为70%乙醇溶液,加热回流提取2小时,获得第二提取液,过滤,获得第二过滤液,将第一过滤液和第二过滤液合并,搅拌混合,减压浓缩、除去乙醇,获得干膏体,随后采用粉碎机将所得干膏体粉碎,粉碎粒度370目,获得粉末状的所述中药添加剂。
实施例3中药添加剂3
本发明实施例提供了一种治疗母猪子宫炎的中药添加剂,由以下重量份数的原料药材制成:金银花18重量份、马鬃参17重量份、黄柏22重量份、车前子25重量份、猪苓25重量份、蝤蛴20重量份、泽泻18重量份、甘草22重量份、簕竹19重量份、当归20重量份、川芎18重量份、益母草17重量份、黄芪18重量份、花萆薢19重量份、穿心莲22重量份、苦参17重量份、鱼腥草18重量份、肾蕨22重量份、青蒿25重量份、紫苏18重量份、丝带蕨19重量份、山药27重量份、淫羊藿19重量份、五味子18重量份、庵摩勒15重量份、芦巴子22重量份、枳壳18重量份、亚黑管菌22重量份、乌药18重量份、锦葵18重量份、簕欓18重量份、海螵蛸20重量份和大萼鹿角藤25重量份。
中药添加剂通过以下制备方法制得:
步骤一、按照重量份数称取所有原料药材,并粉碎成60目的粉末状;
步骤二、将上述所得粉末进行炭炒2.5小时,随后加入相对于混合物质量4倍的醇浓度为85%乙醇溶液,加热回流提取7小时,获得第一提取液,过滤,获得第一过滤液;滤渣再次加入相对于其质量2-5倍的醇浓度为90%乙醇溶液,加热回流提取3小时,获得第二提取液,过滤,获得第二过滤液,将第一过滤液和第二过滤液合并,搅拌混合,减压浓缩、除去乙醇,获得干膏体,随后采用粉碎机将所得干膏体粉碎,粉碎粒度400目,获得粉末状的所述中药添加剂。
毒性试验
1、蓄积毒性试验报告
选用20只健康小白鼠,雌、雄各10只,以本发明实施例1的中药添加剂为对象,剂量设计每7天为一期,每期剂量分别为0.10LD50 、0.20LD50 、0.25LD50 、0.30LD 50 、0.40LD50 ,此样品的雌性、雄性小鼠的LD 50均为4000m份/k份BW(五个剂量为500、750、1100、1800、2400m份/k份BW)。每7天称体重一次,调整给药量,按0.05ml/10份BW经口灌胃。28天后,动物无死亡情况发生,试验结束,按递增剂量给受试物28天后,雌性、雄性动物均无死亡情况发生。以实施例2和实施例3的中药添加剂为对象,按照上述方法进行毒性试验,结果如实施例1相同。
2、急性毒性试验
应用NIH小鼠40只,SPF级,雌雄各半,体重15~20g,进行急性毒性试验。小鼠随机分为两组,每组20只,即对照组和给药组,实验前禁食12小时;将本发明的实施例1制备的中药添加剂溶解在水中,(浓度为6.75g生药/ml,最高浓度)灌胃,灌胃容积为7ml/kg(即单次给药剂量为28.7生药/kg),对照组给予等量生理盐水,一天给药3次,给药间隔时间8小时,给药后连续观察14天,并记录小鼠的毒性反应及死亡数。实验结果表明:与对照组比较,给药后小鼠未见明显差异,实验连续观察21天,小鼠全身状况、饮食、饮水、体重增长均正常。因此本发明实施例1的中药添加剂的急性毒性低,临床用药安全。以实施例2和实施例3的中药添加剂为对象,按照上述方法进行毒性试验,结果如实施例1相同。
治疗对比试验:
2010年5月-2012年5月,有400头患有子宫炎的母猪,将400头患有子宫炎的母猪随机分成4组,分别为实施例组1、实施例组2、实施例组3和西药治疗组,分别使用实施例1的中药添加剂1、实施例2的中药添加剂2、实施例3的中药添加剂3进行治疗和传统药物进行治疗,其中,实施例组1-3的药量均为每只每日,每千克的饲料中混入30g中药添加剂,治疗期间为10-20天;西药治疗组的传统药物选用氯前列烯醇0.4mg/mL、苯甲酸雌二醇8mg/mL进行颈部注射,每天1次,治疗15-28天;空白对照组不进行任何治疗。治疗结束后观察三个月,记录各组母猪的治愈率和死亡率,结果如表1所示。
其中,疗效判定标准如下:
治愈:患猪体温降至正常,食欲正常,精神良好,阴道排出物消失,乳量未减少,断奶后10-15d,母猪自然发情并受孕;
显效:患猪体温降至正常,食欲转好,精神一般,阴道排出物小时,乳量稍减少,断奶后10-15d,母猪未发情或者发情未受孕;
无效:患猪病情没有减轻或病情加重,或者死亡。
表1各实验组治疗效果对照表
从表1的数据可知:本发明药物对患有子宫炎的母猪的治疗效果明显优于西药治疗组,提高治愈率,降低死亡率。
以上所述仅为本发明的较佳实施例,并不用以限制本发明,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (9)
1.一种治疗母猪子宫炎的中药添加剂,其特征在于,所述中药添加剂包括以下原料药材:金银花、马鬃参、黄柏、车前子、猪苓、蝤蛴、泽泻、甘草、簕竹、当归、川芎、益母草、黄芪、花萆薢、穿心莲、苦参、鱼腥草、肾蕨、青蒿、紫苏、丝带蕨、山药、淫羊藿、五味子、庵摩勒、芦巴子、枳壳、亚黑管菌和乌药。
2.根据权利要求1所述的治疗母猪子宫炎的中药添加剂,其特征在于,所述中药添加剂中各原料药材的重量份数为:金银花15-30重量份、马鬃参10-30重量份、黄柏20-30重量份、车前子20-35重量份、猪苓15-30重量份、蝤蛴10-30重量份、泽泻10-30重量份、甘草20-35重量份、簕竹10-30重量份、当归15-30重量份、川芎10-30重量份、益母草10-30重量份、黄芪15-35重量份、花萆薢10-30重量份、穿心莲20-35重量份、苦参10-30重量份、鱼腥草15-30重量份、肾蕨20-35重量份、青蒿20-35重量份、紫苏15-30重量份、丝带蕨10-30重量份、山药25-35重量份、淫羊藿10-30重量份、五味子15-30重量份、庵摩勒10-30重量份、芦巴子20-35重量份、枳壳10-30重量份、亚黑管菌20-35重量份和乌药15-30重量份。
3.根据权利要求1或2所述的治疗母猪子宫炎的中药添加剂,其特征在于,所述中药添加剂中各原料药材的重量份数为:金银花17-30重量份、马鬃参15-30重量份、黄柏25-30重量份、车前子20-30重量份、猪苓15-25重量份、蝤蛴15-30重量份、泽泻15-30重量份、甘草20-30重量份、簕竹15-30重量份、当归20-30重量份、川芎15-30重量份、益母草15-30重量份、黄芪15-30重量份、花萆薢15-30重量份、穿心莲20-30重量份、苦参15-30重量份、鱼腥草20-30重量份、肾蕨20-30重量份、青蒿25-35重量份、紫苏20-30重量份、丝带蕨15-30重量份、山药25-30重量份、淫羊藿15-30重量份、五味子15-20重量份、庵摩勒15-30重量份、芦巴子25-35重量份、枳壳15-30重量份、亚黑管菌20-30重量份和乌药15-25重量份。
4.根据权利要求1-3任一项所述的治疗母猪子宫炎的中药添加剂,其特征在于,所述中药添加剂中各原料药材的重量份数为:金银花25重量份、马鬃参22重量份、黄柏26重量份、车前子20重量份、猪苓18重量份、蝤蛴17重量份、泽泻18重量份、甘草22重量份、簕竹18重量份、当归22重量份、川芎18重量份、益母草16重量份、黄芪18重量份、花萆薢20重量份、穿心莲22重量份、苦参18重量份、鱼腥草22重量份、肾蕨20重量份、青蒿25重量份、紫苏22重量份、丝带蕨18重量份、山药28重量份、淫羊藿18重量份、五味子17重量份、庵摩勒16重量份、芦巴子28重量份、枳壳19重量份、亚黑管菌22重量份和乌药18重量份。
5.根据权利要求1-4任一项所述的治疗母猪子宫炎的中药添加剂,其特征在于,所述中药添加剂还包括:锦葵、簕欓、海螵蛸和大萼鹿角藤。
6.根据权利要求1-5任一项所述的治疗母猪子宫炎的中药添加剂,其特征在于,所述中药添加剂中各原料药材的重量份数为:金银花15-30重量份、马鬃参10-30重量份、黄柏20-30重量份、车前子20-35重量份、猪苓15-30重量份、蝤蛴10-30重量份、泽泻10-30重量份、甘草20-35重量份、簕竹10-30重量份、当归15-30重量份、川芎10-30重量份、益母草10-30重量份、黄芪15-35重量份、花萆薢10-30重量份、穿心莲20-35重量份、苦参10-30重量份、鱼腥草15-30重量份、肾蕨20-35重量份、青蒿20-35重量份、紫苏15-30重量份、丝带蕨10-30重量份、山药25-35重量份、淫羊藿10-30重量份、五味子15-30重量份、庵摩勒10-30重量份、芦巴子20-35重量份、枳壳10-30重量份、亚黑管菌20-35重量份、乌药15-30重量份、锦葵10-25重量份、簕欓15-30重量份、海螵蛸10-35重量份和大萼鹿角藤20-30重量份。
7.根据权利要求1-6任一项所述的治疗母猪子宫炎的中药添加剂,其特征在于,所述中药添加剂中各原料药材的重量份数为:金银花20重量份、马鬃参18重量份、黄柏22重量份、车前子22重量份、猪苓18重量份、蝤蛴15重量份、泽泻18重量份、甘草22重量份、簕竹18重量份、当归17重量份、川芎15重量份、益母草18重量份、黄芪19重量份、花萆薢20重量份、穿心莲22重量份、苦参19重量份、鱼腥草20重量份、肾蕨22重量份、青蒿25重量份、紫苏20重量份、丝带蕨18重量份、山药28重量份、淫羊藿18重量份、五味子17重量份、庵摩勒20重量份、芦巴子25重量份、枳壳18重量份、亚黑管菌25重量份、乌药19重量份、锦葵15重量份、簕欓25重量份、海螵蛸18重量份和大萼鹿角藤22重量份。
8.根据权利要求1-7任一项所述的治疗母猪子宫炎的中药添加剂,其特征在于,所述中药添加剂中各原料药材的重量份数为:金银花18重量份、马鬃参17重量份、黄柏22重量份、车前子25重量份、猪苓25重量份、蝤蛴20重量份、泽泻18重量份、甘草22重量份、簕竹19重量份、当归20重量份、川芎18重量份、益母草17重量份、黄芪18重量份、花萆薢19重量份、穿心莲22重量份、苦参17重量份、鱼腥草18重量份、肾蕨22重量份、青蒿25重量份、紫苏18重量份、丝带蕨19重量份、山药27重量份、淫羊藿19重量份、五味子18重量份、庵摩勒15重量份、芦巴子22重量份、枳壳18重量份、亚黑管菌22重量份、乌药18重量份、锦葵18重量份、簕欓18重量份、海螵蛸20重量份和大萼鹿角藤25重量份。
9.根据权利要求1-8任一项所述的治疗母猪子宫炎的中药添加剂,其特征在于,所述制备方法包括以下步骤:
步骤一、按照重量份数称取所有原料药材,并粉碎成40目-60目的粉末;
步骤二、将上述所得粉末进行炭炒1.0-2.5小时,随后加入相对于混合物质量2-4倍的醇浓度为75%-85%乙醇溶液,加热回流提取4.5-7小时,获得第一提取液,过滤,获得第一过滤液;滤渣再次加入相对于其质量2-5倍的醇浓度为65%-90%乙醇溶液,加热回流提取1.5-3小时,获得第二提取液,过滤,获得第二过滤液,将第一过滤液和第二过滤液合并,搅拌混合,减压浓缩、除去乙醇,获得干膏体,随后采用粉碎机将所得干膏体粉碎,粉碎粒度270目-400目,获得粉末状的所述中药添加剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410194402.XA CN103977279A (zh) | 2014-05-09 | 2014-05-09 | 一种治疗母猪子宫炎的中药添加剂及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410194402.XA CN103977279A (zh) | 2014-05-09 | 2014-05-09 | 一种治疗母猪子宫炎的中药添加剂及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103977279A true CN103977279A (zh) | 2014-08-13 |
Family
ID=51269606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410194402.XA Pending CN103977279A (zh) | 2014-05-09 | 2014-05-09 | 一种治疗母猪子宫炎的中药添加剂及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103977279A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105232880A (zh) * | 2015-11-20 | 2016-01-13 | 宋磊 | 一种治疗母猪热毒壅盛型子宫炎的中药添加剂及其制备方法 |
| CN106889325A (zh) * | 2017-02-13 | 2017-06-27 | 漳州傲农牧业科技有限公司 | 一种母猪营养保健的饲料添加剂及其制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101618134A (zh) * | 2008-07-06 | 2010-01-06 | 王丽平 | 一种中药治疗猪慢性子宫炎症的方法 |
| CN102058790A (zh) * | 2009-11-17 | 2011-05-18 | 张其权 | 一种治疗猪慢性子宫炎症的中药 |
-
2014
- 2014-05-09 CN CN201410194402.XA patent/CN103977279A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101618134A (zh) * | 2008-07-06 | 2010-01-06 | 王丽平 | 一种中药治疗猪慢性子宫炎症的方法 |
| CN102058790A (zh) * | 2009-11-17 | 2011-05-18 | 张其权 | 一种治疗猪慢性子宫炎症的中药 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105232880A (zh) * | 2015-11-20 | 2016-01-13 | 宋磊 | 一种治疗母猪热毒壅盛型子宫炎的中药添加剂及其制备方法 |
| CN106889325A (zh) * | 2017-02-13 | 2017-06-27 | 漳州傲农牧业科技有限公司 | 一种母猪营养保健的饲料添加剂及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103520578B (zh) | 一种治疗口腔溃疡的中药组合物及其制备方法 | |
| CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
| CN104187172B (zh) | 用于治疗乌龟肠胃炎病的功能性饲料及其制备方法 | |
| CN104012798A (zh) | 用于治疗母猪子宫内膜炎的饲料、中药组合物及制备方法 | |
| CN103933509A (zh) | 用于治疗淡水鱼水霉病的药物及其制备方法 | |
| CN105213941A (zh) | 一种用于治疗小儿腹泻的中药组合物及其制备方法 | |
| CN104069474A (zh) | 一种治疗脂溢性脱发的中药组合物及其制备方法 | |
| CN103705685B (zh) | 一种治疗产后缺乳的中药制剂 | |
| CN103656048A (zh) | 用于治疗奶牛乳房炎的药物及其制备方法 | |
| CN103977372A (zh) | 一种用于治疗猪流行性腹泻的中药添加剂及其制备方法 | |
| CN103285294B (zh) | 一种用于预防与治疗先兆流产的中药及其制备方法 | |
| CN105797112A (zh) | 一种具有缓释效果的治疗母猪子宫炎的饲料添加剂 | |
| CN105435131A (zh) | 一种治疗慢性心衰的中药组合物及其制备方法 | |
| CN105267696A (zh) | 一种用于肾阴虚型慢性肾盂肾炎的中药丸剂及制备方法 | |
| CN104771585A (zh) | 一种治疗急性肾炎的中药组合物及制备方法 | |
| CN104288518A (zh) | 一种治疗宫颈炎的中药组合物 | |
| CN104173973A (zh) | 一种治疗痢疾的口服液及其制备方法 | |
| CN104225256A (zh) | 一种治疗火毒内陷型烧伤的中药及制备方法 | |
| CN102526390A (zh) | 一种治疗妇科阴道炎的中药制剂 | |
| CN105363005A (zh) | 紫荆皮中药酒 | |
| CN105497782A (zh) | 一种用于治疗肾石症的中药丸剂及制备方法 | |
| CN105267895A (zh) | 用于治疗牛产后血瘀型胞衣不下的药物及其制备方法 | |
| CN102940869B (zh) | 一种治疗猪腹泻的中药组合物 | |
| CN105311527A (zh) | 一种用于治疗子宫内膜移位症的中药制剂及其制备方法 | |
| CN106310018A (zh) | 一种预防和治疗湿疹的中药组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140813 |
|
| RJ01 | Rejection of invention patent application after publication |